BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32700132)

  • 21. Elucidation of pathophysiology and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioids and pain.
    Kanjhan R
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):397-403. PubMed ID: 8582088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripherally acting opioid analgesics and peripherally-induced analgesia.
    Martínez V; Abalo R
    Behav Pharmacol; 2020 Apr; 31(2&3):136-158. PubMed ID: 32168025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal delivery of analgesics in experimental models of pain and analgesia.
    Fairbanks CA
    Adv Drug Deliv Rev; 2003 Aug; 55(8):1007-41. PubMed ID: 12935942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Future pain treatment].
    Rygh LJ; Fagerlund TH; Svendsen F
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1917-22. PubMed ID: 11488183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current and Future Issues in the Development of Spinal Agents for the Management of Pain.
    Yaksh TL; Fisher CJ; Hockman TM; Wiese AJ
    Curr Neuropharmacol; 2017; 15(2):232-259. PubMed ID: 26861470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central analgesic effects of aspirin-like drugs.
    Bannwarth B; Demotes-Mainard F; Schaeverbeke T; Labat L; Dehais J
    Fundam Clin Pharmacol; 1995; 9(1):1-7. PubMed ID: 7768482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pain mechanisms and management: an update.
    Siddall PJ; Cousins MJ
    Clin Exp Pharmacol Physiol; 1995 Oct; 22(10):679-88. PubMed ID: 8575103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioids in the brain: supraspinal mechanisms in pain control.
    Jensen TS
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):123-32. PubMed ID: 9061095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats.
    Hsieh GC; Pai M; Chandran P; Hooker BA; Zhu CZ; Salyers AK; Wensink EJ; Zhan C; Carroll WA; Dart MJ; Yao BB; Honore P; Meyer MD
    Br J Pharmacol; 2011 Jan; 162(2):428-40. PubMed ID: 20880025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesia.
    Shah S; Davis T; Yoburn BC
    Life Sci; 1994; 55(19):1451-8. PubMed ID: 7968211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the spinal actions of the mu-opioid remifentanil with alfentanil and morphine in the rat.
    Buerkle H; Yaksh TL
    Anesthesiology; 1996 Jan; 84(1):94-102. PubMed ID: 8572360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action.
    Sawynok J; Esser MJ; Reid AR
    J Psychiatry Neurosci; 2001 Jan; 26(1):21-9. PubMed ID: 11212590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of Analgesic and Other Pain-Relief Drugs to Manage Chronic Low Back Pain: Results from a National Survey.
    Gouveia N; Rodrigues A; Ramiro S; Eusébio M; Machado PM; Canhão H; Branco JC
    Pain Pract; 2017 Mar; 17(3):353-365. PubMed ID: 27206719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The analgesic effect of low dose focal irradiation in a mouse model of bone cancer is associated with spinal changes in neuro-mediators of nociception.
    Vit JP; Ohara PT; Tien DA; Fike JR; Eikmeier L; Beitz A; Wilcox GL; Jasmin L
    Pain; 2006 Jan; 120(1-2):188-201. PubMed ID: 16360279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventional approaches to pain management.
    Markman JD; Philip A
    Anesthesiol Clin; 2007 Dec; 25(4):883-98, viii. PubMed ID: 18054151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible mechanisms of morphine analgesia.
    Lipp J
    Clin Neuropharmacol; 1991 Apr; 14(2):131-47. PubMed ID: 1849794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol.
    Badeaux J; Bonanno L; Au H
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):27-38. PubMed ID: 26447005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A D2-like receptor family agonist produces analgesia in mechanonociception but not in thermonociception at the spinal cord level in rats.
    Almanza A; Simón-Arceo K; Coffeen U; Fuentes-García R; Contreras B; Pellicer F; Mercado F
    Pharmacol Biochem Behav; 2015 Oct; 137():119-25. PubMed ID: 26303304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.